Perrigo Company plc (NYSE:PRGO), a leading provider of over-the-counter health and wellness solutions, has seen its stock price touch a 52-week low, dipping to $24.09. This latest price level reflects a significant downturn from the stock's performance over the past year, with Perrigo experiencing a 1-year change of -20.38%. The decline to this 52-week low underscores the challenges faced by the company in a competitive market, as investors and analysts closely monitor its strategies for recovery and growth amidst broader economic pressures.
In other recent news, Perrigo Company plc has been undergoing significant transformations. Amid a multiyear restructuring plan, the company's stock rating was downgraded from Buy to Hold by a leading investment firm. The firm also adjusted Perrigo's price target to $30.00 from the previous $50.00. This development is part of Perrigo's recent financial and strategic maneuvers, including the pricing of $715 million of 6.125% Senior Notes and €350 million of 5.375% Senior Notes, due in 2032.
Perrigo's second quarter financial results for 2024 showed a decline in organic net sales, largely due to challenges in the infant formula regulatory environment. However, the company reaffirmed its full-year earnings per share (EPS) outlook and announced the appointment of Dr. David Ball (NYSE:BALL) as the Executive Vice President and Chief Brand and Digital Officer.
Despite these challenges, Perrigo is projecting a decrease of -1% to -3% in its net sales growth outlook for 2024, with an adjusted EPS outlook of $2.50 to $2.65. Meanwhile, Kenvue Inc 's stock maintains a Neutral rating with Piper Sandler, citing mixed personal care trends. These are the recent developments for both Perrigo and Kenvue Inc. (NYSE:KVUE)
InvestingPro Insights
Perrigo's recent stock performance aligns with several key insights from InvestingPro. The company's stock is currently trading near its 52-week low, as highlighted in the article, which is corroborated by InvestingPro data. Despite this challenging position, Perrigo maintains a strong dividend profile, with InvestingPro Tips noting that the company has raised its dividend for 21 consecutive years and maintained payments for 22 years. This commitment to shareholder returns is further emphasized by a current dividend yield of 4.53%.
While the company's recent financial performance has been mixed, with revenue declining by 4.36% over the last twelve months, there are signs of potential improvement. InvestingPro Tips indicate that net income is expected to grow this year, and analysts predict the company will return to profitability. This optimism is reflected in the fact that two analysts have revised their earnings upwards for the upcoming period.
For investors considering Perrigo's current valuation, it's worth noting that the stock's Price to Book ratio stands at 0.73, suggesting it may be undervalued relative to its assets. However, the company's adjusted P/E ratio of 55.46 indicates a high earnings multiple compared to historical norms.
InvestingPro offers additional insights, with 7 more tips available for Perrigo, providing a more comprehensive analysis for those looking to delve deeper into the company's prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.